FDA Approved: LIVMARLI — Supplemental Application (Mirum Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for LIVMARLI (maralixibat chloride) from Mirum Pharmaceuticals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alagille Syndrome

Drugs mentioned

• LIVMARLI (Maralixibat chloride)

Snippet

SUPPL AP for LIVMARLI (MARALIXIBAT CHLORIDE)